SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

UpDog Crypto is currently trending due to its highly active community consistently engaging with the popular 'Whats UpDog?' meme, a core part of its identity on the Solana blockchain. Enthusiasts are celebrating its sustained presence as a long-term meme coin and actively encouraging wider participation, framing current levels as a prime opportunity for entry.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community buzzes about its significant partnership with World Liberty Financial for USD1 payroll integration and ongoing discussions for potential collaborations with Ripple and Stellar. Investors are highlighting ZBCN's real-world utility in payments, near-complete token supply distribution, and the anticipated SuperApp launch as key drivers for substantial future growth. This positions Zebec as a compliant, foundational payment solution poised for broad adoption within the crypto space.

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is trending due to its provocative name and association with similarly-themed meme coins, sparking widespread amusement and disbelief within the community. Investors are engaging in ironic "all in" declarations and debating the speculative nature of such assets. This trend underscores a segment of the crypto market driven purely by internet culture and humorous, high-risk plays.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is capturing attention as an "OG privacy coin" amid discussions about its rumored collaboration with POL and recent integration with ACH, signaling expanded utility. The community is actively observing its movements, with many anticipating significant upside and comparing its potential to recent rallies in other privacy tokens like Zcash, fueled by its low market cap and scarce supply.

Alchemy Pay

Alchemy Pay (ACH) is trending amid significant expansion in its payment gateway capabilities, driven by new integrations like Ripple's RLUSD stablecoin and securing additional U.S. Money Transmitter Licenses. The community is buzzing about its strategic pivot to a stablecoin-centric Layer-1 blockchain and its growing suite of compliant fiat-to-crypto on-ramps, positioning ACH as a vital bridge between traditional finance and the Web3 ecosystem.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo Finance is trending as it strengthens its position in real-world asset (RWA) tokenization following the closure of a multi-year SEC investigation without charges and recent EU approval to offer tokenized stocks and ETFs. The community is actively discussing ONDO's foundational work in bridging traditional finance with blockchain, anticipating significant growth in enabling 24/7 trading for institutional assets, while also monitoring upcoming token unlocks.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is trending due to mixed reactions surrounding its recent earnings, where the discontinuation of a pain drug program briefly overshadowed solid financial performance and a robust pipeline. Despite this, community conversation is heavily focused on the promising advancements in its kidney and Type 1 Diabetes programs, alongside the growing adoption of its gene therapy, Casgevy. Analysts and investors are increasingly highlighting the company's long-term growth potential, anticipating further catalysts from its diversified portfolio.

Avino Silver & Gold Mines Ltd. engages in the mining and exploration activities. It focuses on silver reserves in the Durango region of North Central Mexico. It operates through the Silver, Gold, and Copper segments. The company was founded on May 15, 1968 and is headquartered in Vancouver, Canada.

Avino Silver & Gold Mines Ltd.

Avino Silver & Gold Mines is trending as investors increasingly expect a substantial re-rating of silver miners, which many believe remain undervalued compared to a surging spot silver price. Community discussions frequently cite strong conviction in silver's imminent breakout due to perceived market manipulation, ongoing supply deficits, and industrial demand, alongside anticipation for the La Preciosa resource update.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix (OCUL) is a major talking point following reports that Sanofi (SNY) is preparing an improved acquisition offer after an initial $16 per share bid was reportedly rejected. The community largely believes the board's rejection signals confidence in the substantial value of its AXPAXLI wet AMD treatment, especially ahead of the anticipated Phase 3 SOL-1 data. This has fueled widespread speculation about a potential higher buyout, as Sanofi looks to strategically enter the multi-billion-dollar retinal market.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is attracting significant attention following recent acquisitions of new anticoagulant assets and progress in manufacturing its lead candidate, tecarfarin, which is supported by a collaboration with Abbott for its Phase 3 trial. The community is sharply divided, with proponents highlighting the low float and potential market opportunity for tecarfarin in rare cardiovascular conditions, while critics frequently raise concerns about ongoing dilution and cash burn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Princeton Bancorp, Inc. (NASDAQ:BPRN) Short Interest Down 30.3% in December

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 37,540 shares, a...

Princeton Bancorp (NASDAQ:BPRN) Trading Up 1.1% - Here's What Happened

Princeton Bancorp (NASDAQ:BPRN) Trading Up 1.1% - Should You Buy...

Princeton Bancorp (NASDAQ:BPRN) Director Martin Tuchman Purchases 1,056 Shares

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) Director Martin Tuchman acquired 1,056 shares of the firm's stock in a transaction that occurred on Wednesday, November 19th. The stock was...

Princeton Bancorp (NASDAQ:BPRN) Director Acquires $64,600.00 in Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) Director Martin Tuchman bought 2,000 shares of Princeton Bancorp stock in a transaction dated Thursday, November 20th. The shares were acquired...

Princeton Bancorp (NASDAQ:BPRN) Director Acquires $34,056.00 in Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) Director Martin Tuchman bought 1,056 shares of the firm's stock in a transaction that occurred on Wednesday, November 19th. The shares were...

Matthew Clark Sells 1,500 Shares of Princeton Bancorp (NASDAQ:BPRN) Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) insider Matthew Clark sold 1,500 shares of the company's stock in a transaction that occurred on Wednesday, November 12th. The shares were sold...

Princeton Bancorp (NASDAQ:BPRN) Director Martin Tuchman Buys 5,000 Shares

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) Director Martin Tuchman acquired 5,000 shares of the company's stock in a transaction that occurred on Wednesday, November 12th. The shares...

Insider Buying: Princeton Bancorp (NASDAQ:BPRN) Director Acquires 5,000 Shares of Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) Director Martin Tuchman bought 5,000 shares of the company's stock in a transaction that occurred on Wednesday, November 12th. The stock was...

Martin Tuchman Buys 493 Shares of Princeton Bancorp (NASDAQ:BPRN) Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) Director Martin Tuchman bought 493 shares of Princeton Bancorp stock in a transaction that occurred on Friday, November 7th. The stock was...

Insider Buying: Princeton Bancorp (NASDAQ:BPRN) Director Purchases 2,000 Shares of Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) Director Martin Tuchman acquired 2,000 shares of Princeton Bancorp stock in a transaction that occurred on Tuesday, November 4th. The stock was...

Princeton Bancorp, Inc. operates as a bank holding company. It is a full-service financial institution that provides business and personal banking. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The company was founded in 2017 and is headquartered in Princeton, NJ.

Current Price	$36.50
Prev Close	$36.66
Open	$36.39
Dividend Yield	3.49%
50-Day Moving Average	$34.44
Beta	0.60
Avg. Volume	10,420.27
PE Ratio	14.19

52-Week High	$36.95
52-Week Low	$27.25
Market Capitalization	$255.14M
EPS (Annual)	$1.55
Price to Book	0.93
Revenue Per Employee	$530,716.60
Enterprise Value/EBITDA	N/A

BPRN
Bank of Princeton

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BPRN News

BPRNBank of Princeton